跳至主要内容
临床试验/DRKS00034174
DRKS00034174尚未招募不适用

Prospective analysis of the influence of the heart-lung machine on factor XII activity in the blood and its functional effects on coagulation capacity, bleeding and thrombosis rates

MU Klinikum München0 个研究点目标入组 20 人开始时间: 2024年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients undergoing major cardiac surgery with intraoperative use of the heart-lung machine
  • - Consent of the patient or caregiver
  • - Age > 18 years

排除标准

  • - Refusal to participate in the study by the patient or caregiver
  • - Age < 18 years
  • - Congenital or acquired coagulation disorders (both pro- and anticoagulatory)
  • - Blood-thinning medication in a time window of less than 12 hours before the operation, with the exception of antiplatelet agents

研究者

发起方
MU Klinikum München

相似试验